{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:08:51Z","timestamp":1794539331652,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The drug resistance is one of the challenges in cancer chemotherapy, due to the development of different drug-efflux pumps that expels the drug out of the cells, thus, searching for new compounds with multiple targets in tumor cells, could be an affordable chemotherapy. Alternariol monomethyl ether (AME) was preliminary recognized as a cytotoxic compound, however, its availability and equivocal activity are the hurdles for further applications.\n                    <jats:italic>Alternaria alternata<\/jats:italic>\n                    EFBL-025, PV342518.1\n                    <jats:italic>,<\/jats:italic>\n                    endophyte of\n                    <jats:italic>Catharanthus roseus,<\/jats:italic>\n                    exhibited the highest AME productivity (550 \u03bcg\/l). Chemically, the structure of putative compound of\n                    <jats:italic>A. alternata<\/jats:italic>\n                    was committed from the TLC, HPLC and LC-MS\/MS, with molecular mass 274.2 m\/z, and typical fragmentation pattern of authentic AME. The purified AME of\n                    <jats:italic>A. alternata<\/jats:italic>\n                    exhibited a substantial activity against the MCF-7 (IC\n                    <jats:sub>50<\/jats:sub>\n                    2.5 \u03bcM), HepG-2 (IC\n                    <jats:sub>50<\/jats:sub>\n                    3.5 \u03bcM), Caco2 (IC\n                    <jats:sub>50<\/jats:sub>\n                    3.9 \u03bcM), compared to OEC (IC\n                    <jats:sub>50<\/jats:sub>\n                    13.5 \u03bcM), i.e with selectivity indices 5.4, 3.9 and 3.5, respectively. The AME has a highest inhibitory activity of Topoisomerase II (IC\n                    <jats:sub>50<\/jats:sub>\n                    10.2 nM), than Topoisomerase I (IC\n                    <jats:sub>50<\/jats:sub>\n                    16.7 nM), with a noticeable ability to arrest the division of MCF-7 cells at the G2\/M and S phases by 1.5 and 2 folds, respectively, compared to the control. The AME of\n                    <jats:italic>A. alternata<\/jats:italic>\n                    significantly induces the total apoptosis, early apoptosis and necrosis of MCF-7 by 20, 22 and 2.9 folds. The docking analysis showed that AME had a favorable binding affinity for topoisomerases I\/II with binding scores -7.72 and -6.06 kcal\/mol, normalized to camptothecin and etoposide that have binding scores -9.44 and -6.82 kcal\/mol, respectively. The molecular dynamics simulations explored the reliable stability of protein-AME complexes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-51757-8","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:23:36Z","timestamp":1779139416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of Alternaria alternata alternariol monomethyl ether with a potential antiproliferative activity by topoisomerases inhibition; molecular docking and dynamic simulations"],"prefix":"10.1038","volume":"16","author":[{"given":"Ashraf S. A.","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa O.","family":"Aboelez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend A. A.","family":"Ezelarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassneim M.","family":"Ewedah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf F.","family":"El-Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amgad M.","family":"Rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"El-Mekkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"51757_CR1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand, U. et al. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10, 1367\u2013401 (2023).","journal-title":"Genes Dis."},{"key":"51757_CR2","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","volume":"68","author":"VT DeVita","year":"2008","unstructured":"DeVita, V. T. & Chu, E. A history of cancer chemotherapy. Cancer Res 68, 8643\u201353 (2008).","journal-title":"Cancer Res"},{"key":"51757_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1200\/JCO.2009.23.6406","volume":"28","author":"AA Adjei","year":"2009","unstructured":"Adjei, A. A. et al. Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non\u2013Small-Cell Lung Cancer: NCCTG and SWOG Study N0426. Journal of Clinical Oncology. 28, 614 (2009).","journal-title":"Journal of Clinical Oncology."},{"key":"51757_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091013","author":"JMA Delou","year":"2019","unstructured":"Delou, J. M. A., Souza, A. S. O., Souza, L. C. M. & Borges, H. L. Highlights in resistance mechanism pathways for combination therapy. Cells https:\/\/doi.org\/10.3390\/cells8091013 (2019).","journal-title":"Cells"},{"key":"51757_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"C Sawyers","year":"2004","unstructured":"Sawyers, C. Targeted cancer therapy. Nature 432, 294\u20137 (2004).","journal-title":"Nature"},{"key":"51757_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.114.217208","volume":"351","author":"G Mattheolabakis","year":"2014","unstructured":"Mattheolabakis, G. et al. Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: A study of phospho-ibuprofen. J. Pharmacol. Exp. Ther. 351, 61\u20136 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"51757_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4161\/cc.7.7.5625","volume":"7","author":"MS Poruchynsky","year":"2008","unstructured":"Poruchynsky, M. S. et al. Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition. Cell Cycle 7, 940\u20139 (2008).","journal-title":"Cell Cycle"},{"key":"51757_CR8","first-page":"789","volume":"6","author":"Y Pommier","year":"2006","unstructured":"Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nature Reviews Cancer 6:10. Nature Publishing Group 6, 789\u2013802 (2006).","journal-title":"Nature Publishing Group"},{"key":"51757_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/acs.jmedchem.9b00726","volume":"63","author":"\u017d Skok","year":"2020","unstructured":"Skok, \u017d, Zidar, N., Kikelj, D. & Ila\u0161, J. Dual inhibitors of human DNA Topoisomerase II and other cancer-related targets. J. Med. Chem. 63, 884\u2013904 (2020).","journal-title":"J. Med. Chem."},{"key":"51757_CR10","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1021\/ja00968a057","volume":"88","author":"ME Wall","year":"1966","unstructured":"Wall, M. E. et al. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata 1,2. J. Am. Chem. Soc. 88, 3888\u20133890 (1966).","journal-title":"J. Am. Chem. Soc."},{"key":"51757_CR11","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1021\/ja00738a045","volume":"93","author":"MC Wani","year":"1971","unstructured":"Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P. & Mcphail, A. T. Plant antitumor agents. I. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia2. J. Am. Chem. Soc. 93, 2325\u20137 (1971).","journal-title":"J. Am. Chem. Soc."},{"key":"51757_CR12","first-page":"1","volume":"22","author":"ASA El-Sayed","year":"2023","unstructured":"El-Sayed, A. S. A., George, N. M., Abou-Elnour, A., El-Mekkawy, R. M. & El-Demerdash, M. M. Production and bioprocessing of camptothecin from Aspergillus terreus, an endophyte of Cestrum parqui, restoring their biosynthetic potency by Citrus limonum peel extracts. Microbial Cell Factories. BioMed Central 22, 1\u201314 (2023).","journal-title":"Microbial Cell Factories. BioMed Central"},{"key":"51757_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02281-23","volume":"11","author":"AM Rady","year":"2023","unstructured":"Rady, A. M. et al. Proteomics and metabolomics analyses of camptothecin-producing Aspergillus terreus reveal the integration of PH domain-containing proteins and peptidylprolyl cis\/trans isomerase in restoring the camptothecin biosynthesis. Microbiol. Spectr. 11, 02281 (2023).","journal-title":"Microbiol. Spectr."},{"key":"51757_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-023-02158-3","volume":"22","author":"A Eldeghidy","year":"2023","unstructured":"Eldeghidy, A., Abdel-Fattah, G., El-Sayed, A. S. A. & Abdel-Fattah, G. G. Production, bioprocessing and antiproliferative activity of camptothecin from Aspergillus terreus, endophyte of Cinnamomum camphora: Restoring their biosynthesis by indigenous microbiome of C. camphora. Microb. Cell Fact. 22, 143 (2023).","journal-title":"Microb. Cell Fact."},{"key":"51757_CR15","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/molecules27093033","volume":"27","author":"ASA El-Sayed","year":"2022","unstructured":"El-Sayed, A. S. A. et al. Production, Bioprocessing and Anti-Proliferative Activity of Camptothecin from Penicillium chrysogenum, &ldquo;An Endozoic of Marine Sponge, Cliona sp. &rdquo;, as a Metabolically Stable Camptothecin Producing Isolate. Molecules 27, 3033 (2022).","journal-title":"Molecules"},{"key":"51757_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114304","volume":"236","author":"A Talukdar","year":"2022","unstructured":"Talukdar, A., Kundu, B., Sarkar, D., Goon, S. & Mondal, M. A. Topoisomerase I inhibitors: Challenges, progress and the road ahead. Eur. J. Med. Chem. 236, 114304 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"51757_CR17","doi-asserted-by":"publisher","first-page":"709075","DOI":"10.3389\/fcell.2021.709075","volume":"9","author":"HY Fan","year":"2021","unstructured":"Fan, H. Y. et al. Insight into the molecular mechanism of podophyllotoxin derivatives as anticancer drugs. Front. Cell. Dev. Biol. 9, 709075 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"51757_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrc2608","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss, J. L. DNA topoisomerase II and its growing repertoire of biological functions. Nat. Rev. Cancer 9, 327 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"51757_CR19","first-page":"63","volume":"4","author":"SG Davey","year":"2020","unstructured":"Davey, S. G. Engineering etoposide. Nature Reviews Chemistry. Nature Research 4, 63 (2020).","journal-title":"Nature Research"},{"key":"51757_CR20","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa042715","volume":"352","author":"AR Mistry","year":"2005","unstructured":"Mistry, A. R. et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med. 352, 1529\u201338 (2005).","journal-title":"N. Engl. J. Med."},{"key":"51757_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/1061186X.2017.1380655","volume":"26","author":"U Kanwal","year":"2018","unstructured":"Kanwal, U. et al. Advances in nano-delivery systems for doxorubicin: An updated insight. J. Drug Target. 26, 296\u2013310 (2018).","journal-title":"J. Drug Target."},{"key":"51757_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","volume":"22","author":"M Cagel","year":"2017","unstructured":"Cagel, M., Grotz, E., Bernabeu, E., Moretton, M. A. & Chiappetta, D. A. Doxorubicin: Nanotechnological overviews from bench to bedside. Drug Discov. Today 22, 270\u201381 (2017).","journal-title":"Drug Discov. Today"},{"key":"51757_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.biopha.2013.09.007","volume":"68","author":"A Alpsoy","year":"2014","unstructured":"Alpsoy, A., Yasa, S. & G\u00fcnd\u00fcz, U. Etoposide resistance in MCF-7 breast cancer cell line is marked by multiple mechanisms. Biomed. Pharmacother. 68, 351\u20135 (2014).","journal-title":"Biomed. Pharmacother."},{"key":"51757_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/toxins14120824","volume":"14","author":"SY Woo","year":"2022","unstructured":"Woo, S. Y. et al. Natural occurrence of Alternaria toxins in agricultural products and processed foods marketed in South Korea by LC\u2013MS\/MS. Toxins 14, 824 (2022).","journal-title":"Toxins"},{"key":"51757_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules18055891","author":"J Lou","year":"2013","unstructured":"Lou, J., Fu, L., Peng, Y. & Zhou, L. Metabolites from Alternaria fungi and their bioactivities. Molecules https:\/\/doi.org\/10.3390\/molecules18055891 (2013).","journal-title":"Molecules"},{"key":"51757_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/15569543.2024.2392118","volume":"43","author":"V Safavizadeh","year":"2024","unstructured":"Safavizadeh, V. et al. The occurrence of tenuazonic acid in food products: A systematic review. Toxin Rev. 43, 453\u201362 (2024).","journal-title":"Toxin Rev."},{"key":"51757_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mnfr.200700379","volume":"53","author":"M Fehr","year":"2009","unstructured":"Fehr, M. et al. Alternariol acts as a topoisomerase poison, preferentially affecting the II\u03b1 isoform. Mol. Nutr. Food Res. 53, 441\u201351 (2009).","journal-title":"Mol. Nutr. Food Res."},{"key":"51757_CR28","unstructured":"Raper KB, Fennell DI. The Genus Aspergillus. Williams and Wilkins; 1965."},{"key":"51757_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","volume":"78","author":"RA Samson","year":"2014","unstructured":"Samson, R. A. et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud. Mycol. 78, 141\u201373 (2014).","journal-title":"Stud. Mycol."},{"key":"51757_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.simyco.2015.07.001","volume":"82","author":"JHC Woudenberg","year":"2015","unstructured":"Woudenberg, J. H. C. et al. Alternaria section Alternaria: Species, formae speciales or pathotypes?. Studies in mycology. Stud Mycol 82, 1\u201321 (2015).","journal-title":"Studies in mycology. Stud Mycol"},{"key":"51757_CR31","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1007\/s11033-022-07271-x","volume":"49","author":"ASA El-Sayed","year":"2022","unstructured":"El-Sayed, A. S. A., Zayed, R. A., El-Baz, A. F. & Ismaeil, W. M. Bioprocesses optimization and anticancer activity of camptothecin from Aspergillus flavus, an endophyte of in vitro cultured Astragalus fruticosus. Mol. Biol. Rep. 49, 4349\u201364 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"51757_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-024-02495-x","volume":"23","author":"S Refaat","year":"2024","unstructured":"Refaat, S., Fikry, E., Tawfeek, N. & El-SayedEl-DomiatyEl-Shafae, A. S. A. M. M. A. M. Production and bioprocessing of epothilone B from Aspergillus niger, an endophyte of Latania loddegesii, with a conceivable biosynthetic stability: Anticancer, anti-wound healing activities and cell cycle analysis. Microb. Cell Fact. 23, 1\u201318 (2024).","journal-title":"Microb. Cell Fact."},{"key":"51757_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-5-113","volume":"5","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: A multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5, 113 (2004).","journal-title":"BMC Bioinformatics"},{"key":"51757_CR34","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura, K. et al. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731\u20139 (2011).","journal-title":"Mol. Biol. Evol."},{"key":"51757_CR35","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s12161-015-0338-9","volume":"9","author":"C Juan","year":"2016","unstructured":"Juan, C., Chamari, K., Oueslati, S. & Ma\u00f1es, J. Rapid Quantification Method of Three Alternaria Mycotoxins in Strawberries. Food Analytical Methods Springer, New York LLC 9, 1573\u20131579 (2016).","journal-title":"Food Analytical Methods Springer, New York LLC"},{"key":"51757_CR36","doi-asserted-by":"crossref","unstructured":"El-Sayed, A. S. A. et al. Conjugation of Aspergillus flavipes taxol with porphyrin increases the anticancer activity of taxol and ameliorates its cytotoxic effects. Molecules, 25 (2) (2020).","DOI":"10.3390\/molecules25020263"},{"key":"51757_CR37","doi-asserted-by":"publisher","first-page":"109718","DOI":"10.1016\/j.enzmictec.2020.109718","volume":"143","author":"ASA El-Sayed","year":"2021","unstructured":"El-Sayed, A. S. A. et al. Production and bioprocess optimization of antitumor Epothilone B analogue from Aspergillus fumigatus, endophyte of Catharanthus roseus, with response surface methodology. Enzyme Microb. Technol. 143, 109718 (2021).","journal-title":"Enzyme Microb. Technol."},{"key":"51757_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/095535491820873191","volume":"3","author":"AH Cory","year":"1991","unstructured":"Cory, A. H., Owen, T. C., Barltrop, J. A. & Cory, J. G. Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture. Cancer Commun. 3, 207\u201312 (1991).","journal-title":"Cancer Commun."},{"key":"51757_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(06)00403-9","volume":"7","author":"AD Bates","year":"1997","unstructured":"Bates, A. D. & Maxwell, A. DNA topology: Topoisomerases keep it simple. Curr. Biol. 7, 778 (1997).","journal-title":"Curr. Biol."},{"key":"51757_CR40","first-page":"683","volume":"20","author":"HAA Ezelarab","year":"2023","unstructured":"Ezelarab, H. A. A., Hassan, H. A., Abuo-Rahma, G. E. D. A. & Abbas, S. H. Design, synthesis, and biological investigation of quinoline\/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents. J. Iranian Chem Soc. Springer Science and Business Media Deutschland GmbH 20, 683\u2013700 (2023).","journal-title":"J. Iranian Chem Soc. Springer Science and Business Media Deutschland GmbH"},{"key":"51757_CR41","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1007\/s00044-021-02798-3","volume":"30","author":"HAA Ezelarab","year":"2021","unstructured":"Abdel-Fatah S.S., El-Sherbiny G.M., khalaf M., Baz A.F.E., El-Sayed A.S.A., El-Batal A.I. Boosting the Anticancer Activity of Aspergillus flavus \u201cendophyte of Jojoba\u201d Taxol via Conjugation with Gold Nanoparticles Mediated by \u03b3-Irradiation. (2022) Applied Biochemistry and Biotechnology, 194 (8), pp. 3558 \u2013 3581.","journal-title":"Med. Chem. Res."},{"key":"51757_CR42","doi-asserted-by":"publisher","first-page":"28608","DOI":"10.1039\/D4RA04165H","volume":"14","author":"HMAHAA El-LateefEzelarab","year":"2024","unstructured":"El-LateefEzelarab, H. M. A. H. A. A. et al. Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFRWT and EGFRT790M: Integrating biological, molecular docking, and ADMET analysis. RSC Adv. 14, 28608\u201328625 (2024).","journal-title":"RSC Adv."},{"key":"51757_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140720","volume":"1324","author":"AM Ahmed","year":"2025","unstructured":"Ahmed, A. M. et al. New S- and N-alkyl functionalized bis-1,2,4-Triazolyl-based derivatives as potential dual EGFRWT and EGFRT790M inhibitors: Synthesis, anti-proliferative evaluation, molecular docking study and ADMET studies. J. Mol. Struct. 1324, 140720 (2025).","journal-title":"J. Mol. Struct."},{"key":"51757_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11030-024-10867-z","volume":"29","author":"AYA Alzahrani","year":"2025","unstructured":"Alzahrani, A. Y. A. et al. Design, spectroscopic characterizations, and biological investigation of oxospiro[chromine-4,3-indolene]-based compounds as promising antiproliferative EGFR inhibitors and antimicrobial agents. Molecular diversity. 29, 471\u2013487 (2025).","journal-title":"Molecular diversity."},{"key":"51757_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pbi.2006.05.004","volume":"9","author":"BJ Howlett","year":"2006","unstructured":"Howlett, B. J. Secondary metabolite toxins and nutrition of plant pathogenic fungi. Curr. Opin. Plant Biol. 9, 371\u2013375 (2006).","journal-title":"Curr. Opin. Plant Biol."},{"key":"51757_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.py.21.090183.000511","volume":"21","author":"S Nishimura","year":"1983","unstructured":"Nishimura, S. & Kohmoto, K. Host-specific toxins and chemical structures from Alternaria species. Annu. Rev. Phytopathol. 21, 87\u2013116 (1983).","journal-title":"Annu. Rev. Phytopathol."},{"key":"51757_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.toxrep.2019.06.021","volume":"6","author":"M Meena","year":"2019","unstructured":"Meena, M. & Samal, S. Alternaria host-specific (HSTs) toxins: An overview of chemical characterization, target sites, regulation and their toxic effects. Toxicol. Rep. 6, 745\u2013758 (2019).","journal-title":"Toxicol. Rep."},{"key":"51757_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01451","volume":"8","author":"M Meena","year":"2017","unstructured":"Meena, M. et al. Alternaria toxins: Potential virulence factors and genes related to pathogenesis. Front. Microbiol. 8, 1451 (2017).","journal-title":"Front. Microbiol."},{"key":"51757_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3920\/WMJ2008.x013","volume":"1","author":"V Ostry","year":"2008","unstructured":"Ostry, V. Alternaria mycotoxins: An overview of chemical characterization, producers, toxicity, analysis and occurrence in foodstuffs. World Mycotoxin J. 1, 175\u201388 (2008).","journal-title":"World Mycotoxin J."},{"key":"51757_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12550-017-0290-1","volume":"33","author":"S Hickert","year":"2017","unstructured":"Hickert, S. et al. Alternaria toxins in South African sunflower seeds: cooperative study. Mycotoxin Research. Springer Verlag 33, 309\u201321 (2017).","journal-title":"Mycotoxin Research. Springer Verlag"},{"key":"51757_CR51","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.foodres.2018.01.032","volume":"106","author":"S De Berardis","year":"2018","unstructured":"De Berardis, S. et al. Determination of four Alternaria alternata mycotoxins by QuEChERS approach coupled with liquid chromatography-tandem mass spectrometry in tomato-based and fruit-based products. Food Research International. 106, 677\u201385 (2018).","journal-title":"Food Research International."},{"key":"51757_CR52","doi-asserted-by":"crossref","unstructured":"Ravenstein SX Van, Mehta KP, Kavlashvili T, Byl JAW, Zhao R, Osheroff N, et al. Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms. The EMBO Journal [Internet]. Springer Science and Business Media LLC; 2022;41.","DOI":"10.15252\/embj.2022110632"},{"key":"51757_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.toxlet.2013.02.012","volume":"219","author":"A Solhaug","year":"2013","unstructured":"Solhaug, A. et al. Alternariol induces abnormal nuclear morphology and cell cycle arrest in murine RAW 264.7 macrophages. Toxicol. Lett. 219, 8\u201317 (2013).","journal-title":"Toxicol. Lett."},{"key":"51757_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxlet.2015.08.1107","volume":"239","author":"A Solhaug","year":"2015","unstructured":"Solhaug, A. et al. The mycotoxin alternariol induces DNA damage and modify macrophage phenotype and inflammatory responses. Toxicol. Lett. 239, 9\u201321 (2015).","journal-title":"Toxicol. Lett."},{"key":"51757_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tox.2014.10.009","volume":"326","author":"A Solhaug","year":"2014","unstructured":"Solhaug, A., Torgersen, M. L., Holme, J. A., Lagadic-Gossmann, D. & Eriksen, G. S. Autophagy and senescence, stress responses induced by the DNA-damaging mycotoxin alternariol. Toxicology 326, 119\u201329 (2014).","journal-title":"Toxicology"},{"key":"51757_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.toxlet.2008.08.005","volume":"182","author":"K Wollenhaupt","year":"2008","unstructured":"Wollenhaupt, K., Schneider, F. & Tiemann, U. Influence of alternariol (AOH) on regulator proteins of cap-dependent translation in porcine endometrial cells. Toxicol. Lett. 182, 57\u201362 (2008).","journal-title":"Toxicol. Lett."},{"key":"51757_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden, K. H. & Prives, C. Blinded by the light: The growing complexity of p53. Cell 137, 413\u201331 (2009).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51757-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:02:43Z","timestamp":1779145363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51757-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51757-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study doesn\u2019t contain any studies with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15352"}}